Literature DB >> 31399802

Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-making.

Luca Giovanella1,2, Frederik A Verburg3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31399802     DOI： 10.1007/s00259-019-04476-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  8 in total

1.  Letter to the editor: Use of radioactive iodine treatment in patients with hyperthyroidism? A case for shared decision making.

Authors:  Tristan Struja; Philipp Schuetz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-03       Impact factor: 9.236

2.  (131)I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies.

Authors:  F A Verburg; M Luster; M Lassmann; C Reiners
Journal:  Nuklearmedizin       Date:  2010-12-17       Impact factor: 1.379

3.  Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.

Authors:  Neige M Y Journy; Marie-Odile Bernier; Michele M Doody; Bruce H Alexander; Martha S Linet; Cari M Kitahara
Journal:  Thyroid       Date:  2017-07-06       Impact factor: 6.568

4.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Authors:  Douglas S Ross; Henry B Burch; David S Cooper; M Carol Greenlee; Peter Laurberg; Ana Luiza Maia; Scott A Rivkees; Mary Samuels; Julie Ann Sosa; Marius N Stan; Martin A Walter
Journal:  Thyroid       Date:  2016-10       Impact factor: 6.568

Review 5.  Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective.

Authors:  Lars C Moeller; Dagmar Führer
Journal:  Endocr Relat Cancer       Date:  2013-03-22       Impact factor: 5.678

6.  Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.

Authors:  E Ron; M M Doody; D V Becker; A B Brill; R E Curtis; M B Goldman; B S Harris; D A Hoffman; W M McConahey; H R Maxon; S Preston-Martin; M E Warshauer; F L Wong; J D Boice
Journal:  JAMA       Date:  1998 Jul 22-29       Impact factor: 56.272

7.  Cancer Incidence and Mortality in Patients Treated Either With RAI or Thyroidectomy for Hyperthyroidism.

Authors:  Essi Ryödi; Saara Metso; Pia Jaatinen; Heini Huhtala; Rauni Saaristo; Matti Välimäki; Anssi Auvinen
Journal:  J Clin Endocrinol Metab       Date:  2015-08-11       Impact factor: 5.958

8.  Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism.

Authors:  Cari M Kitahara; Amy Berrington de Gonzalez; Andre Bouville; Aaron B Brill; Michele M Doody; Dunstana R Melo; Steven L Simon; Julie A Sosa; Mark Tulchinsky; Daphnée Villoing; Dale L Preston
Journal:  JAMA Intern Med       Date:  2019-08-01       Impact factor: 21.873
  8 in total
  1 in total

1.  "Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide" on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news.

Authors:  Luca Giovanella; Frederik A Verburg; Petra Petranović Ovčariček; Ioannis Iakovou; Jasna Mihailovic; Alexis Vrachimis; Slimane Zerdoud; Martha Hoffmann; Markus Luster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-06       Impact factor: 9.236
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.